U2Bio Co (XKRX:221800) FCF Margin % : 9.62% (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is U2Bio Co FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. U2Bio Co's Free Cash Flow for the six months ended in Dec. 2023 was ₩1,337 Mil. U2Bio Co's Revenue for the six months ended in Dec. 2023 was ₩13,904 Mil. Therefore, U2Bio Co's FCF Margin % for the quarter that ended in Dec. 2023 was 9.62%.

As of today, U2Bio Co's current FCF Yield % is -7.50%.

The historical rank and industry rank for U2Bio Co's FCF Margin % or its related term are showing as below:

XKRX:221800' s FCF Margin % Range Over the Past 10 Years
Min: -12.7 Med: -2.62 Max: 33.71
Current: -11.47

During the past 9 years, the highest FCF Margin % of U2Bio Co was 33.71%. The lowest was -12.70%. And the median was -2.62%.

XKRX:221800's FCF Margin % is ranked worse than
50.45% of 222 companies
in the Medical Diagnostics & Research industry
Industry Median: -11.3 vs XKRX:221800: -11.47

U2Bio Co FCF Margin % Historical Data

The historical data trend for U2Bio Co's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

U2Bio Co FCF Margin % Chart

U2Bio Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-7.87

4.28

24.46

33.71

-11.47

U2Bio Co Semi-Annual Data
	Jun22	Dec22	Jun23	Dec23
FCF Margin %	10.10	90.25	-28.84	9.62

Competitive Comparison of U2Bio Co's FCF Margin %

For the Diagnostics & Research subindustry, U2Bio Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

U2Bio Co's FCF Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, U2Bio Co's FCF Margin % distribution charts can be found below:

* The bar in red indicates where U2Bio Co's FCF Margin % falls into.

U2Bio Co FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

U2Bio Co's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-3532.491	/	30792.037
	=	-11.47 %

U2Bio Co's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	1337.307	/	13904.222
	=	9.62 %

U2Bio Co FCF Margin % Related Terms

Thank you for viewing the detailed overview of U2Bio Co's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

U2Bio Co (XKRX:221800) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » U2Bio Co Ltd (XKRX:221800) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Basement 1, 68 Gumaro Songpagu, Seoul, KOR

Website

http://www.u2bio.co.kr

U2Bio Co Ltd provides vitro diagnostic test services. The company is engaged in offering general diagnostic tests, molecular diagnostic tests, and breastfeeding nutritional analysis services among others.

U2Bio Co (XKRX:221800) Headlines

No Headlines